NLRP3 and early-onset autosomal dominant Alzheimer disease: Existing studies have demonstrated that dysregulated NLRP3 inflammasome activation is closely associated with the pathogenesis of various major human diseases, including atherosclerosis, hypertension, type 2 diabetes, Alzheimer’s disease, and gout [3,4].